US Stock MarketDetailed Quotes
ACST Acasti Pharma
- 2.4500
- +0.0499+2.08%
Close Aug 23 16:00 ET
- 2.4500
- 0.00000.00%
Post 20:01 ET
24.84MMarket Cap-2333P/E (TTM)
2.5000High2.4000Low8.48KVolume2.4400Open2.4001Pre Close20.62KTurnover0.18%Turnover RatioLossP/E (Static)10.14MShares3.590052wk High0.42P/B11.38MFloat Cap1.720052wk Low--Dividend TTM4.65MShs Float2016.0000Historical High--Div YieldTTM4.17%Amplitude1.7200Historical Low2.4300Avg Price1Lot Size
About Acasti Pharma Company
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.
Company Profile
SymbolACST
Company NameAcasti Pharma
Listing DateJan 7, 2013
Founded2002
CEOMr. Prashant Kohli
MarketNASDAQ
Employees7
Fiscal Year Ends03-31
Address103 Carnegie Center,Suite 300
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-818-839-4378
Websitehttp://www.acasti.com
Company Executives
- Name
- Position
- Salary
- Prashant Kohli
- Chief Executive Officer and Director
- 415.51K
- Dr. R. Loch Macdonald, M.D.,PhD
- Chief Medical Officer
- --
- Robert J. DelAversano
- Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- --
- Carrie D'Andrea
- Vice President, Clinical Operations
- --
- Amresh Kumar, PhD
- Vice President of Program Management
- --
- Vimal Kavuru
- Chairman of the Board
- 96.19K
- Dr. S. George Kottayil
- Director
- 406.23K
- Edward Neugeboren
- Independent Director
- --
- A. Brian Davis
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg